Stephen Lane Nesbitt

President/Interested Trustee Stephen Lane Nesbitt bought 40,487 shares of CCLFX at $10.25 on 2026-07-07 for $415,000.00

Stephen Lane Nesbitt, as President/Interested Trustee, purchased 40,487 shares at $10.25, increasing his holdings from 11,180,821 shares to 11,221,309 shares. This represents a modest portfolio addition of +0.4% relative to his pre-transaction holdings. The purchase is his fifth documented open-market buy at CCLFX following prior acquisitions on 2026-01-09, 2025-12-11, 2025-11-25, 2025-07-10, and 2025-05-07. None of the prior same-ticker outcomes are yet measurable at the 30-day or 90-day marks, limiting historical performance assessment at this specific security. His broader cross-ticker track record shows 10 prior open-market buys, though outcomes on those positions are not detailed here.

President Nesbitt Stephen Lane purchases 28,680 shares of CCLFX at $10.46 for $300,000 on 2026-01-09

Nesbitt Stephen Lane, serving as President/Interested Trustee of Cliffwater Corporate Lending Fund, executed a purchase of 28,680 shares at $10.46 for a total value of $300,000.00. This transaction increased his holdings from 11,152,140 shares to 11,180,821 shares, representing a net increase of 0.3% against his pre-transaction position. The insider has demonstrated a consistent pattern of accumulation at this ticker, with 5 prior trades at CCLFX, including three additional buys within the prior two months (2025-12-11, 2025-11-25, and 2025-07-10), indicating sustained interest in the position. However, because these recent purchases lack measurable 90-day performance outcomes due to their recency, the pattern reflects intent rather than demonstrated timing accuracy.

President Lane purchases 1,433,714 shares in 2 transactions totaling $15,266,629.62 at blended average $10.65

Nesbitt Stephen Lane, President and Interested Trustee, executed 2 separate purchases totaling 1,433,714 shares for $15,266,629.62 ($15.3M), increasing his holdings by 1,433,714 shares or 14.8% versus pre-transaction holdings of 9,718,425 shares. The purchases occurred at $10.63 on 2025-11-25 (777,669 shares) and $10.67 on 2025-12-11 (656,044 shares), with a blended average price of $10.65. This represents a material financial commitment from a senior officer at Cliffwater Corporate Lending Fund (CCLFX). His cross-ticker track record shows 7 prior open-market buys, though prior same-ticker trades at CCLFX (three buys in 2024–2025) lack measurable 90-day outcomes, providing limited context for evaluating timing accuracy at this specific fund. The magnitude of this purchase relative to his existing position warrants examination of the fund's fundamental backdrop and capital structure.

President/Interested Trustee buys 330,812 shares of CCLFX for $3,500,000 at $10.58; adds 3.5% to holdings.

Nesbitt Stephen Lane purchased 330,812 shares of Cliffwater Corporate Lending Fund at $10.58 per share, bringing his total holdings from 9,387,613 shares to 9,718,425 shares. The transaction represents a $3,500,000.00 commitment. This is the third open-market purchase of CCLFX by this insider within approximately one year; prior buys occurred on 2025-05-07 and 2024-09-13, though outcomes on those trades are not yet measurable at 90-day intervals. Across his broader transaction history, Lane has completed 6 prior open-market purchases on other tickers, but his prior same-ticker trades at CCLFX do not yet demonstrate a pattern of well-timed entry.

President/Interested Trustee Nesbitt Stephen Lane purchased 52,687 shares at $18.98 ($1.0M) on 2025-07-10, raising holdings 6.3%.

Nesbitt Stephen Lane, in his capacity as President/Interested Trustee, deployed $1,000,000.00 to acquire 52,687 shares of CPEFX at $18.98 on 2025-07-10, increasing his post-transaction holdings to 893,847 shares. This purchase marks the 7th discretionary open-market buy in his cross-ticker track record of 6 prior buys, representing a material commitment in dollar terms and a 6.3% increase to his existing position. The magnitude and timing of this transaction relative to his existing 841,160-share base warrant review of contemporaneous market conditions and fund-specific developments to assess whether this reflects opportunistic accumulation or a sustained conviction pattern in the fund.

Nesbitt Stephen Lane purchased 321,691 shares of CELFX for $3,499,999.99 on 2025-07-10, boosting holdings to 3,883,882 shares.

Nesbitt Stephen Lane, President/Interested Trustee, acquired 321,691 shares at $10.88 for a total of $3,499,999.99, increasing his holdings by 321,691 shares from 3,562,191 to 3,883,882 shares. This transaction represents a significant $3.5M capital deployment by an insider. Lane's prior transaction history at CELFX includes a buy on 2025-05-07 and a buy on 2023-10-26, though neither prior trade yet has measurable 90-day outcomes. His broader cross-ticker track record shows 6 prior open-market buys; timing outcomes on those prior buys are not yet measurable at the 90-day mark. The concentration of his holdings—nearly 3.88M shares—and repeated accumulation in this security over time warrant investor attention to understand the rationale driving these purchases and the underlying fundamentals of the fund.

President Lane purchases 2,000,046 shares of CCLFX at $10.65 for $21,300,500.00, increasing holdings 27.1%

Nesbitt Stephen Lane, President/Interested Trustee, executed a substantial open-market purchase of 2,000,046 shares at $10.65, increasing his total holdings from 7,387,566 shares to 9,387,613 shares—a 27.1% net increase in his position. This represents a significant capital commitment of $21,300,500.00 by an executive in a position of strategic authority. Lane has completed 3 prior open-market buys in his track record across all tickers, and this follows a prior purchase at CCLFX on 2024-09-13 where outcome measurement at the 90-day mark is not yet available. The transaction size and concentration in a single company signal material confidence in the fund, though the lack of prior measurable timing data at this specific ticker limits historical pattern assessment.

CELFX President Nesbitt Stephen Lane purchases 1,948,810 shares for $21,300,500 on 2025-05-07, nearly doubling holdings from 1.96M to 3.91M shares.

Nesbitt Stephen Lane, in his capacity as President and Interested Trustee, executed a substantial open-market purchase of 1,948,810 shares at $10.93 per share, representing a 99.3% increase to his holdings at CELFX. The magnitude of capital deployed ($21,300,500) and the doubling of his position from 1,962,218 shares to 3,911,028 shares constitutes a material concentration event. His cross-ticker track record shows 3 prior buys, though same-ticker timing outcomes at CELFX remain unmeasurable (only 1 prior trade on 2023-10-26). The absence of a measurable 90-day outcome on prior CELFX activity limits inference about his historical execution quality specifically at this fund.

Nesbitt Stephen Lane purchases 459,136 shares of CCLFX at $10.89 for $5,000,000

Nesbitt Stephen Lane, President and Interested Trustee of Cliffwater Corporate Lending Fund, purchased 459,136 shares at $10.89 on 2024-09-13 totaling $5,000,000, bringing his holdings to 7,387,566 shares (a 6.6% increase). This represents his second open-market transaction across all tickers in his tracked history. The substantial dollar commitment of $5,000,000 to a single purchase reflects material capital deployment by an insider with fiduciary responsibilities at the fund, though the absence of prior same-ticker transaction history limits the ability to assess any established pattern of accumulation activity at this specific security.